Target of replication: *A priori* experimental protocols, materials, and confirmatory analysis plans were peer reviewed, [pre-registered][1], and published by [*eLife*][2].
This component includes all primary data, analysis scripts, and QC data for the replication of the experiment reported in Figure 3B and S6B-C of [Berger et al., 2012][3]. This experiment was performed to assess the impact of PREX2 expression on tumor growth and tumor free survival in mice injected with NRAS<sup>G12D</sup> melanocytes stabily expressing GFP, PREX2<sup>WT</sup>, PREX2<sup>G844D</sup>, or PREX2<sup>Q1430*</sup>.
## Contents
[Figures Component][4] contains a visualization of replication results. These figures are the same as can be found in the Replication Study and include Figures 3 and 4.
[Statistical Analyses Component][5] contains R scripts that were used for the analysis.
[Data Component][6] contains data generated from the experimental work and files used in the analysis and generation of figures, which are in .csv format.
[Methods Component][7] contains methodology details for this replication attempt which were described in the [Registered Report][2].
[Cell line quality control data][8] includes results confirming the cell lines were free of mycoplasma contamination as well as STR DNA profiling of the cell lines used.
[1]: https://osf.io/rvyg5/
[2]: https://elifesciences.org/content/3/e04180
[3]: http://www.nature.com/nature/journal/v485/n7399/full/nature11071.html
[4]: https://osf.io/pqyks/wiki/home/
[5]: https://osf.io/z9mhg/wiki/home/
[6]: https://osf.io/jvra5/wiki/home/
[7]: https://osf.io/gnm64/wiki/home/
[8]: https://osf.io/dhch3/wiki/home/